Despite HPV vaccines, screening will remain central for decades to control cervical cancer.
Recently, HPV testing alone or with cytology was introduced as an alternative to cytology …

Human papillomaviruses (HPVs) are the necessary cause of most cervical cancers, a large
proportion of other anogenital cancers, and a subset of oropharyngeal cancers. The …

Testing for DNA of 13 high‐risk HPV types with the Hybrid Capture 2 (HC2) test has
consistently been shown to perform better in triage of women with cervical cytology results …

Background Cervical cancer screening participation is suboptimal in most settings. We
assessed whether human papillomavirus (HPV) self-sampling may increase screening …

Background: High-risk human papillomavirus (hrHPV) testing to triage women with minor
cervical lesions generates many referrals. Purpose: To evaluate the accuracy of genotyping …

The best method for identifying women who have minor cervical lesions that require
diagnostic workup remains unclear. The authors of this report performed a meta‐analysis to …

Background: Several options for the triage of high-risk HPV screen–positive (hrHPV+)
women were assessed. Methods: This study incorporated CIN2+ cases and controls, all of …

Background High-risk human papillomavirus (HPV) test is replacing cytology as the primary
cervical cancer screening test due to superior sensitivity, but in most countries women≥ 65 …

Introduction Human papillomavirus (HPV) testing as the primary cervical cancer screening
method is implemented in several countries. We report data from the first round of a large …

In a Norwegian pilot, triage of high-risk human papillomavirus (hrHPV)-positive women with
reflex cytology followed by hrHPV testing 12 months later, yielded 82% of women referred to …